Zimmer Biomet Holdings (ZBH) Revenue — Quarter Ended Mar 31, 2024
Revenue for the quarter decreased compared to the prior quarter but increased compared to the same quarter last year. The company reported higher net sales year over year, while sequential performance showed a decline.
Key takeaway
Quarter ended Mar 31, 2024 · FY2024 Q1
Revenue for the quarter decreased compared to the prior quarter but increased compared to the same quarter last year. The company reported higher net sales year over year, while sequential performance showed a decline.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1.9B
Revenue reported for this quarter.
Quarter-over-quarter
-2.6%
Change from the immediately preceding quarter.
Year-over-year
+3.2%
Change from the comparable year-ago quarter.
Trailing four quarters
$7.5B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2023 | $1.9B | +4.9% |
| Sep 30, 2023 | $1.8B | +5.0% |
| Dec 31, 2023 | $1.9B | +6.3% |
| Mar 31, 2024 | $1.9B | +3.2% |
Revenue performance
Revenue moved lower from the immediately preceding quarter, reflecting a sequential contraction. However, compared to the same period a year ago, revenue grew.
Quarterly comparison
The year-over-year increase was supported by higher net sales as shown in the financial statements. The sequential decline contrasts with the prior quarter's growth trend.
What to watch
The substantial rise in restructuring and cost reduction initiatives may affect future expense levels.